Minerva Neurosciences, Inc. – In Connection With Johnson & Johnsons (J&J) Pending Acquisition of Actelion Ltd (The Pending Acquisition), J&J and Minerva Neurosciences, Inc. (Minerva) Have Mutually Agreed to the Terms Set Forth in the Binding Term Sheet Attached Hereto as Annex a and Incorporated Herein (The Binding Term Sheet) With Respect to J&Js Ongoing Relationship With Minerva. (May 31st, 2017)
This letter agreement and the Binding Term Sheet are intended to be a legally binding agreement between J&J and Minerva and set forth the material terms of the agreement between the parties with respect to the matters described therein. J&J and Minerva further agree to negotiate in good faith, and reach agreement on, definitive documentation to effect the agreement in the Binding Term Sheet as promptly as practicable following the date hereof. This letter agreement and the Binding Term Sheet may only be terminated in the event that J&J abandons the Pending Acquisition.
Minerva Neurosciences, Inc. – August 1, 2016 Dear Mark: (August 4th, 2016)
This agreement (hereafter "Employment Agreement") will formalize the amended and restated terms and conditions of your employment with Minerva Neurosciences, Inc. (the "Company").
Minerva Neurosciences, Inc. – Common Stock Purchase Agreement (March 18th, 2016)
THIS COMMON STOCK PURCHASE AGREEMENT (this "Agreement") is made as of March 17, 2016 by and between Minerva Neurosciences, Inc. a Delaware corporation (the "Corporation") and David Kupfer (the "Purchaser").